Why BGPT?
logo

Check Claims Before You Publish

See how your reported results read as versioned evidence records β€” linked to experiments and limitations.Know what the science actually supports before you trust the answer.

Press Enter ↡ to review claims


     Quick Explanation



    M A Riddle β€” scientific strength review (data-limited)
    Based on the only quantitative author data provided (h-index/citations/paper count and a short list of titled papers), the author appears to have published across multiple areas, but the scientific evidence available here is insufficient to judge methodological rigor of each study (e.g., study design, controls, effect sizes, reproducibility).



     Long Explanation



    Author Review: M A Riddle
    Date context: July 14, 2026. This review is skeptical and data-limited: I can only evaluate what is explicitly provided in your prompt (author-level citation metrics + a short list of paper titles), not the full-text methods/results of each cited work.
    1) Reported citation metrics (quantitative signal)
    • Prompt-provided metrics: h-index 3, total citations 37, paper count 6.
    • OpenAlex disambiguation note: your OpenAlex payload also contains a different high-impact β€œMark A. Riddle” profile (h-index 79, cited_by_count 25661, works_count 281) and multiple other β€œRiddle” variants. Therefore, β€œM A Riddle” in your prompt may be name-collided across distinct researchers.
    • OpenAlex entry relevant to your exact string (β€œM A Riddle”): works_count 1, cited_by_count 156, h_index 1 (still ambiguous without full bibliographic disambiguation in this prompt).
    Critical interpretation: Citation metrics are imprecise proxies for methodological rigor. They are also highly vulnerable to (i) author-name conflation, (ii) field citation density differences, and (iii) early-career vs mature-career effects.
    2) Evidence available about the author’s work (from titles only)
    Your prompt provides only paper titles for 6 β€œM A Riddle” papers. Without full-text, I cannot reliably assess: experimental design quality, controls, bias management, statistical power, effect size robustness, data availability, or reproducibility practices.
    Paper title (as provided) Scientific domain (inferred only from title)
    Palliative Care for Refractory Depressive Symptoms in a Female Veteran Geriatric Patient.Clinical psychiatry / case report
    The use of carbamazepine to expedite the metabolism of a long‐acting aripiprazole injectionPharmacology / case-based medication management
    Identifying New Treatments For Memory Disorders: From Mice To MenTranslational review (memory disorders)
    Influenza-Induced Mania.Clinical psychiatry / case report
    MAOI treatment response: multiaxial assessment.Clinical assessment / antidepressant response analysis
    Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid.Clinical assessment / antidepressant response analysis
    Skeptical constraint: titles alone do not identify whether the papers are randomized trials, observational studies, systematic reviews, or case reportsβ€”each has very different implications for evidence strength.
    3) Scientific strengths and likely blind spots (inferred from provided scope)
    • Breadth across clinical psychiatry: the provided titles suggest work spanning mood disorders, antidepressant response assessment, and medication pharmacology/case contexts.
    • Translational framing: at least one title explicitly links mouse-to-human treatment development, which (if substantiated in full text) can be valuable but also carries known translational failure modes.
    • Evidence hierarchy risk: multiple titles look like case reports (β€œFemale Veteran Geriatric Patient”, β€œInfluenza-Induced Mania”), which typically cannot establish causal efficacy and can be highly susceptible to narrative selection and reporting bias.
    Major blind spot introduced by this prompt: without study methods/results, I cannot check core epistemic requirements: risk-of-bias, statistical power, missing data handling, preregistration, blinding, confounding control, subgroup robustness, and data/code availability.
    4) Visual: author-level metric snapshot (from prompt)
    This is a simple bar chart of the prompt-provided author metrics (h-index, total citations, paper count). It does not resolve OpenAlex name ambiguity.
    5) What would change this review?
    • If the correct author is actually the high-impact β€œMark A. Riddle” rather than the low-count β€œM A Riddle” profile, then the scientific quality assessment would likely change substantially.
    • Full-text access would let me audit: study design type, inclusion/exclusion criteria, outcome measures validity, statistical methods, and whether conclusions follow from data.
    • Cross-checking each listed work for data availability and replication attempts could materially change the rigor score.
    Action buttons
    Use the agent when you can provide or fetch full-texts; right now, this prompt contains mostly metadata/titles.


    Feedback:    

    Updated: July 14, 2026

     BGPT Author Review



    Scientific Quality

    40%

    Based on the prompt, the only evaluable quantitative signal for β€œM A Riddle” is low h-index (3) and low citation totals (37 across 6 papers). However, OpenAlex name collisions appear likely (a separate β€œMark A. Riddle” has very different metrics), making attribution uncertain. Without full-text methods/results, I cannot assess rigor, bias control, or reproducibilityβ€”so the score reflects high uncertainty and insufficient evidence, not proven weakness.



    Communication Quality

    60%

    No direct content from the author’s writing is providedβ€”only paper titles and metadataβ€”so communication quality cannot be evaluated. The scope suggests clinical/clinical-science writing, but that remains speculative without abstracts/full text.



    Author Novelty

    40%

    Novelty cannot be determined from titles alone. Some titles imply pharmacologic/case-based observations and translational review framing, but novelty relative to the field requires full-text assessment and citations to contemporaneous work.



    Scientific Rigor

    30%

    Rigor depends on design (RCT vs observational vs case report), bias controls, and statistical validity. Titles alone cannot support a rigor judgment; the presence of multiple case-report-like titles would *tend* to lower average rigor, but that inference is not confirmatory without full text. Attribution ambiguity further reduces confidence.

     Top Data Sources ExportMCP



     Hypothesis Graveyard



    The hypothesis that low h-index (3) definitively implies low scientific rigor is unlikely here because name-collision and field-variance can dominate citation metrics; without full-text design audit, this explanation is too simplistic.


    The hypothesis that translational framing (β€œFrom Mice To Men”) guarantees rigorous translational methodology is unlikely; translational reviews often vary widely in methodology and selection bias without full-text evaluation.

     Science Movie



    Make a narrated HD Science movie for this answer ($32 per minute)




     Discussion


    Stay current without chasing every paper.

    Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.


    My BGPT